RecallDepth
Class II Ongoing

Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ, 07430, Product of India, NDC 68462-562-01

This recall is currently active, issued April 10, 2024. It was issued by Glenmark Pharmaceuticals Inc., Usa.

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
March 26, 2024
Posted
April 10, 2024
Recall Number
D-0430-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
6,528 bottles
Firm Location
Mahwah, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications: Out of Specification (OOS) was reported in test of dissolution at the 12th month time point in long term stability study.

Distribution

Nationwide in the US

Lot / Code Info

Lot #: 17230304, Exp. 12/31/2024.

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls